Target intelligence / Profile preview

Amelogenin, Y isoform (AMELY)

Target
AMELY
Molecular classification
Other (extracellular matrix protein)
01

Overview

Amelogenin, Y isoform (AMELY) is a gene located on the Y chromosome that encodes a form of the amelogenin protein, which is an extracellular matrix protein involved in the biomineralization process during tooth enamel development. Amelogenins form a family of proteins essential for the formation, organization, and mineralization of enamel but the vast majority of amelogenin is produced from the X-linked gene (AMELX); the Y isoform (AMELY) makes only a minor contribution and is not essential for normal enamel formation. AMELY is routinely used in molecular and forensic applications as a sex-determination marker due to its presence only in males. Unlike some protein targets, AMELY is not classified as a receptor, enzyme, ion channel, transporter, or transcription factor. There is no evidence that drugs directly interact with or target AMELY, nor does it play a central role in disease processes, although it is linked to the amelogenin gene family whose dysfunction (AMELX) is responsible for X-linked amelogenesis imperfecta.

Other names
Amelogenin, Y-linkedAMELYAMGLAMGYamelogenin Y-linkedamelogenin (Y chromosome)Amelogenin, Y isoform
02

Biological functions

BiomineralizationTooth enamel developmentOrganization of enamel rodsRegulation of hydroxyapatite crystal growthDevelopment of tooth cementum
03

Disease associations

Other (Forensic sex determination marker)No direct disease role for AMELY; AMELX mutations cause X-linked amelogenesis imperfecta (AI), but AMELY is not known to compensate for AMELX loss
04

Biomarkers

Biomarker for male biological sex in forensic and clinical testing

Beyond the preview

Go deeper on Amelogenin, Y isoform (AMELY).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amelogenin, Y isoform (AMELY).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call